JDRF is pleased to report that Congress has approved a one-year renewal of the Special Diabetes Program (SDP). SDP funding has helped realize some of the most groundbreaking advances in type 1 diabetes (T1D) research possible. JDRF advocates have played an integral role in securing this renewal, which has improved the lives and health of millions of Americans affected by diabetes.
JDRF and other private funders of research can’t do it alone. As the largest charitable supporter of T1D research, JDRF is currently sponsoring $568 million in scientific research in 17 countries. But it is not enough. We need this critical support from the federal government to ensure that promising T1D clinical trials doesn’t slow down or stop altogether.
JDRF advocates have come through again and again. When it mattered most, you urged your Members of Congress to sign the SDP support letter. Now, please join us again by thanking your legislators for supporting this crucial initiative. To help you out, we have messages that are ready to go in our Letter Writing Center!
To learn more about the SDP renewal, read our press release.
Thank you for becoming a JDRF Advocate and turning Type One into Type None.